{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0800" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "In a subgroup analysis, subjects with a baseline fasting plasma glucose (FPG) level in the range of 6.1-6.9 mmol/L demonstrated a non significant lower proportion of IFG at week 12 in the intervention arm compared to the control arm (60.0% vs. 41.7% p = 0.343).",
  "reading_complete" : "2020-08-05T22:16:10Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:09:03Z",
  "trigger" : "level",
  "evidence" : [ "glucose (FPG) level" ],
  "pmc_id" : "7235750",
  "score" : 0
}